# Effect of Metformin Versus Repaglinide Treatment in Non-Obese Type 2 Diabetic Patients Uncontrolled by Diet

> **NCT00118950** · PHASE4 · COMPLETED · sponsor: **Steno Diabetes Center Copenhagen** · enrollment: 100 (—)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Metformin
- **DRUG:** Repaglinide
- **DRUG:** Placebo-Metformin.
- **DRUG:** Placebo-Repaglinide.
- **OTHER:** Diet-only.

## Key facts

- **NCT ID:** NCT00118950
- **Lead sponsor:** Steno Diabetes Center Copenhagen
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-03
- **Primary completion:** —
- **Final completion:** 2003-03
- **Target enrollment:** 100 (—)
- **Last updated:** 2008-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00118950

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00118950, "Effect of Metformin Versus Repaglinide Treatment in Non-Obese Type 2 Diabetic Patients Uncontrolled by Diet". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00118950. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*